Citation: M. Hanel et al., Anti-CD20 monoclonal antibody (Rituximab) and cidofovir as successful treatment of an EBV-associated lymphoma with CNS involvement, ONKOLOGIE, 24(5), 2001, pp. 491-494
Authors:
Hanel, M
Kroger, N
Kroschinsky, F
Birkmann, J
Hanel, A
Herbst, R
Naumann, R
Friedrichsen, K
Ehninger, G
Zander, AR
Fiedler, F
Citation: M. Hanel et al., Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma, J CANC RES, 127(6), 2001, pp. 387-395
Authors:
Hanel, M
Kroger, N
Hoffknecht, MM
Peters, SO
Metzner, B
Fiedler, F
Braumann, D
Schubert, JC
Illiger, HJ
Hanel, A
Kruger, WH
Zeller, W
Weh, HJ
Hossfeld, DK
Zander, AR
Citation: M. Hanel et al., ASHAP - an effective salvage therapy for recurrent and refractory malignant lymphomas, ANN HEMATOL, 79(6), 2000, pp. 304-311
Citation: M. Hanel et al., Determining sedimentation ages of high-grade metamorphic gneisses by theirpalynological record: a case study in the northern Schwarzwald (Variscan Belt, Germany), INT J E SCI, 88(1), 1999, pp. 49-59